Sofie Qiao ^Investor

Sofie Qiao is a seasoned executive with a strong background in biotechnology and pharmaceuticals. With a Ph.D. in Organic Chemistry from MIT and experience at companies like Genzyme and McKinsey, she has a proven track record of success in drug discovery and development. As President and CEO of Virtuoso Therapeutics, she leads a team focused on bi-specific antibody drug discovery for oncology. Sofie's expertise in small molecule drug development and her leadership roles at various companies make her a valuable asset in the industry. She is driven by a passion for innovation and a commitment to advancing healthcare.